Zai Lab (ZLAB) Receivables (2018 - 2026)
Zai Lab (ZLAB) posted quarterly Receivables of $54.1 million for Q1 2026, down 29.37% year-on-year from $76.6 million in Q1 2025, and down 49.05% on a QoQ basis from $106.1 million in Q4 2025.
Zai Lab (ZLAB) Receivables (2018 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Receivables for 9 consecutive years, with $54.1 million the latest figure, recorded in Q1 2026.
- Quarterly Receivables fell 29.37% year-over-year to $54.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.1 million (down 29.37% YoY) and the FY2025 annual result came in at $106.1 million, up 24.58% from the prior year.
- Receivables eased to $54.1 million in Q1 2026 per ZLAB's latest filing, from $106.1 million in the prior quarter.
- Over the last five years, Receivables for ZLAB reached as high as $106.1 million in Q4 2025 and fell as low as $7.8 million in Q4 2023.
- A 5-year average of $49.7 million and a median of $47.3 million in 2023 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables slumped 80.41% — and 2025, when it surged 535.43%.
- Year by year, Receivables stood at $9.3 million in 2022, then retreated by 16.13% to $7.8 million in 2023, then soared by 114.1% to $16.7 million in 2024, then jumped by 535.43% to $106.1 million in 2025, then sank by 49.05% to $54.1 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $54.1 million, $106.1 million, and $85.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | 54.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.07 Mn |
| Dec 31, 2025 | 106.12 Mn |
| Sep 30, 2025 | 85.38 Mn |
| Jun 30, 2025 | 88.50 Mn |
| Mar 31, 2025 | 76.56 Mn |
| Dec 31, 2024 | 16.70 Mn |
| Sep 30, 2024 | 49.97 Mn |
| Jun 30, 2024 | 69.64 Mn |
| Mar 31, 2024 | 60.42 Mn |
| Dec 31, 2023 | 7.80 Mn |
| Sep 30, 2023 | 41.60 Mn |
| Jun 30, 2023 | 47.28 Mn |
| Mar 31, 2023 | 43.35 Mn |
| Dec 31, 2022 | 9.30 Mn |
| Sep 30, 2022 | 27.74 Mn |
| Jun 30, 2022 | 27.05 Mn |
| Mar 31, 2022 | 33.39 Mn |
| Dec 31, 2021 | 47.47 Mn |
| Sep 30, 2021 | 21.02 Mn |
| Jun 30, 2021 | 18.03 Mn |